GFAP and Alzheimer disease: Most candidate proteins that we identified were not highly expressed in CNS cells and only six showed associations with a biomarker of astrocyte-mediated neuroinflammation (GFAP), yet the consistent detection of their differing RNA (and even some protein) concentrations in AD brains suggests that these proteins emanating from peripheral immune cells may be especially important drivers of neurodegeneration.